Palla Pharma Ltd
ASX:PAL
EV/GP
Enterprise Value to Gross Profit
Market Cap | EV/GP | ||||
---|---|---|---|---|---|
AU |
Palla Pharma Ltd
ASX:PAL
|
47.8m AUD | -7.5 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
226.7B USD | 14.6 | ||
US |
Danaher Corp
NYSE:DHR
|
197.8B USD | 8.1 | ||
US |
Agilent Technologies Inc
NYSE:A
|
45.3B USD | 13.5 | ||
CH |
Lonza Group AG
SIX:LONN
|
38.2B CHF | 16.3 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.8B USD | 10.2 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
55.5T KRW | 30.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
32.4B USD | 15.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.4B USD | 12 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
25B USD | 22.5 | ||
US |
Waters Corp
NYSE:WAT
|
21B USD | 13.1 |
EV/GP Forward Multiples
Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.